Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management

Details

Serval ID
serval:BIB_6AB1E50188EB
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management
Journal
Journal of Cardiothoracic and Vascular Anesthesia
Author(s)
Weiss  B. M., von Segesser  L. K., Turina  M. I., Seifert  B., Pasch  T.
ISSN
1053-0770
Publication state
Published
Issued date
06/1996
Peer-reviewed
Oui
Volume
10
Number
4
Pages
464-70
Notes
Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial --- Old month value: Jun
Abstract
OBJECTIVE: To compare two heparin managements for a cardiopulmonary bypass (CPB) procedure with heparin-coated equipment. The hypothesis was that a lower heparin dose may reduce blood loss and homologous transfusion requirements and influence the speed of postoperative recovery. DESIGN: Prospective, randomized, and open study. SETTING: Operating room and intensive care unit in a university hospital. PARTICIPANTS: Twenty-four patients undergoing first-time elective coronary artery surgery. INTERVENTIONS: Heparin-coated CPB equipment (Duraflo II; Baxter-Bentley) was used in all patients. The study group (n = 12) received low-dose (100 IU/kg i.v. and 0 to 1,000 IU/L priming; target level of activated coagulation time [ACT] over 180 seconds during CPB; suction in a red cell washing device); and the control group (n = 12) received high-dose (300 IU/kg i.v. and 5,000 IU/L priming; ACT over 480 seconds; standard cardiotomy suction) heparin management. MEASUREMENTS AND MAIN RESULTS: ACT remained above 200 seconds after the initial heparin dose in the study group for the CPB duration up to 99 minutes. In 11 of 12 patients in the control group, additional heparin was required during CPB. Total doses of heparin and protamine (mean 8,017 v 50,508 IU and 83 v 325 mg, respectively; p < 0.0001), volume of homologous blood transfusion (median 600 v 1450 mL; p < 0.025), and blood products exposure (median 0.5 v 5.0 units/patients; p < 0.05) were significantly lower in the study group. Postoperative chest drainage showed a trend to lower volume loss (median 705 v 930 mL; p < 0.08) in patients managed with low-dose heparin. Oxygenator resistance during CPB, perioperative laboratory analyses (oxygen and metabolic data, hematocrit, platelet count, prothrombin, thrombin, activated partial thromboplastin time, fibrinogen, D-dimers, creatine kinase, and myocardial band of creatine kinase concentration), fluid balance, and the time periods required for extubation, stay in the intensive care unit, and hospital discharge were not different between the groups. There were no evidences of myocardial infarction in any of 24 patients, and all recovered after the procedure. CONCLUSION: Low-dose heparin management enabled uneventful procedures with heparin-coated CPB equipment, significantly decreased protamine and homologous blood requirements, but did not reduce chest drainage or influence the postoperative course and recovery in patients after coronary artery surgery.
Keywords
Adult Aged *Cardiopulmonary Bypass Female Heparin/*administration & dosage Humans Male Middle Aged Prospective Studies Whole Blood Coagulation Time
Pubmed
Web of science
Create date
14/02/2008 14:18
Last modification date
20/08/2019 14:25
Usage data